Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis
- Resource Type
- Abstract
- Source
- In
Osteoarthritis and Cartilage April 2016 24 Supplement 1:S419-S420 - Subject
- Language
- ISSN
- 1063-4584